An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa. [electronic resource]
Producer: 20140317Description: 243-51 p. digitalISSN:- 1097-6787
- Adult
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Hidradenitis Suppurativa -- diagnosis
- Humans
- Injections, Subcutaneous
- Interleukin 1 Receptor Antagonist Protein -- administration & dosage
- Male
- Patient Satisfaction -- statistics & numerical data
- Pilot Projects
- Prospective Studies
- Quality of Life
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.